Form 4: Viemed Healthcare CFO Trae Fitzgerald Reports Transaction in Company Stock
SEC Form 4 Filing
Trae Fitzgerald, CFO of Viemed Healthcare, reports the vesting and settlement of phantom share units, resulting in a change in beneficial ownership of company stock.
Summary
- On May 9, 2024, Trae Fitzgerald, the Chief Financial Officer of Viemed Healthcare, engaged in a transaction involving the vesting and settlement of 1,157 phantom share units.
- These phantom shares, granted under the company's Phantom Share Unit Plan, vested on this date.
- The settlement resulted in Fitzgerald acquiring 1,157 common shares and simultaneously disposing of them for cash at a price of $7.13 per share.
- Following these transactions, Fitzgerald directly owns 66,428 common shares.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, and the transaction itself doesn't inherently indicate positive or negative sentiment. It's a routine part of executive compensation.
Industry Context
Form 4 filings are standard practice for company insiders to report changes in their beneficial ownership of company stock, providing transparency to investors.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding executive compensation and ownership.
Key Dates
| Date | Description |
|---|---|
| 05/09/2024 | Date of transaction: Vesting and settlement of phantom share units. |
| 05/10/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.